Etoricoxib (Arcoxia) is a selective COX-2 inhibitor from Merck Co. Currently it is approved in more than 80 countries worldwide but not in the US, where the Food and Drug Administration (FDA) has required additional safety and efficacy data for etoricoxib before it will issue approval....